Alabama wagers $65M on new biotech complex

Alabama is betting $65 million that its new HudsonAlpha Institute for Biotechnology in Huntsville will prove the launch pad for a burgeoning new biotech industry. One wing of the institute opened for business has already maxed out with 12 biotechs moving in. Another wing is under construction to house researchers--the secret sauce in what economic development officials are fervently hoping will prove a potent mixture of scientific endeavor and commercial know-how. Tenants include Antarus Biotech, Applied Genomics, Conversant Healthcare Systems, CFD Research, Expression Genetics, Extremozyme, Microarrays, New Century Pharmaceuticals, Open Biosystems, Serina Therapeutics, Source CF and Theragnostix Reference Laboratories. And with others looking to join them, new buildings are under consideration.

- read the report from the Birmingham News

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.